Efflux system overexpression and decreased oprd contribute to the carbapenem resistance among extended-spectrum beta-lactamase-producing pseudomonas aeruginosa isolates from a Chinese University hospital

Microbial Drug Resistance

Volumn 19, Issue 6, 2013, Pages 463-468

  Liu, Yang ^a   Li, Xiang Yang ^b   Wan, La Gen ^a   Jiang, Wei Yan ^b   Li, Fang Qu ^b   Yang, Jing Hong ^b  

^a NANCHANG UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENEBORONIC ACID; CARBAPENEM; CEFTAZIDIME; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; MEROPENEM; OUTER MEMBRANE PROTEIN; PORIN;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; CHINESE; EFFUSION; GENE EXPRESSION; GENOTYPE; HUMAN; INTENSIVE CARE UNIT; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NEWBORN INTENSIVE CARE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CHINA; CLONE CELLS; GENE EXPRESSION REGULATION, BACTERIAL; GENE TRANSFER, HORIZONTAL; GENES, MDR; HOSPITALS, UNIVERSITY; HUMANS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MULTILOCUS SEQUENCE TYPING; PLASMIDS; PORINS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84888374037     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2013.0010     Document Type: Article

References (23)

1. [CLSI] Clinical and Laboratory Standards Institute. 2011. Performance Standards for Antimicrobial Susceptibility Testing, Vol. 31, No. 1, 20th Informational Supplement M100-S20. CLSI, Wayne, PA.
2. Elena, R., G. Cabot, X. Mulet, M. Garc?́a-Castillo, R. del Campo, C. Juan, R. Cantó n, and A. Oliver. 2011. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. J. Antimicrob. Chemother. 66:2022-2027.
3. Glupczynski, Y., P. Bogaerts, A. Deplano, C. Berhin, T.D. Huang, J. Van Eldere, and H. Rodriguez-Villalobos. 2010. Detection and characterization of class A extendedspectrum-betalactamase-producing Pseudomonas aeruginosa isolates in Belgian hospitals. J. Antimicrob. Chemother. 65:866-871.
4. Gutiérrez, O., C. Juan, E. Cercenado, F. Navarro, E. Bouza, P. Coll, J.L. Pérez, and A. Oliver. 2007. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob. Agents Chemother. 51:4329-4335.
5. Lee, J.Y., and K.S. Ko. 2012. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-blactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea. Int. J. Antimicrob. Agents 40: 168-172.
6. Lin, S.P., M.F. Liu, C.F. Lin, and Z.Y. Shi. 2012. Phenotypic detection and polymerase chain reaction screening of extended-spectrum b-lactamases produced by Pseudomonas aeruginosa isolates. J. Microbiol. Immunol. Infect. 45:200-207.
7. Liu, Y., X.Y. Li, L.G. Wan, W.Y. Jiang, F.Q. Li, and J.H. Yang. 2012. Molecular characterization of the bla(KPC-2) gene in clinical isolates of carbapenem-resistant Klebsiella pneumoniae from the pediatric wards of a Chinese hospital. Can. J. Microbiol. 58:1167-1173.
8. Ocampo-Sosa, A.A., G. Cabot, C. Rodr?́guez, E. Roman, F. Tubau, M.D. Macia, B. Moya, L. Zamorano, C. Suárez, C. Peñ a, M.A. Dom?́nguez, G. Moncalián, A. Oliver, L. Mart? ́nez-Mart? ́nez, and Spanish Network for Research in Infectious Diseases (REIPI). 2012. Alterations of OprD in carbapenem-intermediate and-susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study. Antimicrob. Agents Chemother. 56:1703-1713.
9. Picão, R.C., L. Poirel, A.C. Gales, and P. Nordmann. 2009. Further identification of CTX-M-2 extended-spectrum betalactamase in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53:2225-2226.
10. Picão, R.C., S.S. Andrade, A.G. Nicoletti, E.H. Campana, G.C. Moraes, R.E. Mendes, and A.C. Gales. 2008. Metallobeta-lactamase detection: comparative evaluation of doubledisk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates. J. Clin. Microbiol. 46:2028-2037.
11. Polotto, M., T. Casella, M.G. de Lucca Oliveira, F.G. Rú bio, M.L. Nogueira, M.T. de Almeida, and M.C. Nogueira. 2012. Detection of P. aeruginosa harboring bla CTX-M-2, bla GES-1 and bla GES-5, bla IMP-1 and bla SPM-1 causing infections in Brazilian tertiary-care hospital. BMC Infect. Dis. 12:176.
12. Quale, J., S. Bratu, J. Gupta, and D. Landman. 2006. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother. 50:1633-1641.
13. Riera, E., G. Cabot, X. Mulet, M. Garc?́a-Castillo, R. del Campo, C. Juan, R. Cantó n, and A. Oliver. 2011. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. J. Antimicrob. Chemother. 66:2022-2027.
14. Rodr?́guez-Mart?́nez, J.M., L. Poirel, and P. Nordmann. 2009. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53:4783-4788.
15. Rodriguez-Martinez, J.-M., L. Poirel, and P. Nordmann. 2009. Extended spectrum cephalosporinases in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53:1766-1771.
16. Shu, J.C., J.H. Chia, L.K. Siu, A.J. Kuo, S.H. Huang, L.H. Su, and T.L. Wu. 2012. Interplay between mutational and horizontally acquired resistance mechanisms and its association with carbapenem resistance amongst extensively drug-resistant Pseudomonas aeruginosa (XDR-PA). Int. J. Antimicrob. Agents 39:217-222.
17. Strateva, T., and D. Yordanov. 2009. Pseudomonas aeruginosa-a phenomenon of bacterial resistance. J. Med. Microbiol. 58(Pt 9):1133-1148.
18. Qu, T.T., J.L. Zhang, J. Wang, J. Tao, Y.S. Yu, Y.G. Chen, J.Y. Zhou, and L.J. Li. 2009. Evaluation of phenotypic tests for detection of metallo-b-lactamase-producing Pseudomonas aeruginosa strains in China. J. Clin. Microbiol. 47:1136-1142.
19. Tenover, F.C., R.D. Arbeit, R.V. Goering, P.A. Mickelsen, B.E. Murray, D.H. Persing, and B. Sweaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
20. Tomá s, M., M. Doumith, M. Warner, J.F. Turton, A. Beceiro, G. Bou, D.M. Livermore, and N. Woodford. 2010. Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob. Agents Chemother. 54:2219-2224.
21. Wang, J., J.Y. Zhou, T.T. Qu, P. Shen, Z.Q. Wei, Y.S. Yu, and L.J. Li. 2010. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals. Int. J. Antimicrob. Agents 35:486-491.
22. Yoo, J.S., J.W. Yang, H.M. Kim, J. Byeon, H.S. Kim, J.I. Yoo, G.T. Chung, and Y.S. Lee. 2012. Dissemination of genetically related IMP-6-producing multidrug-resistant Pseudomonas aeruginosa ST235 in South Korea. Int. J. Antimicrob. Agents 39:300-304.
23. Zhao, W.H., and Z.Q. Hu. 2010. Beta-lactamases identified in clinical isolates of Pseudomonas aeruginosa. Crit. Rev. Microbiol. 36:245-258.